Skip to content

Comparison of Breathing Yoga and Progressive Muscle Relaxation Techniques After Transplantation

Comparison of the Effectiveness of Breathing Yoga and Progressive Muscle Relaxation Techniques in Relieving Pain, Respiratory Complications and Kinesiophobia in Post-Liver Transplant Recipients

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07066384
Enrollment
125
Registered
2025-07-15
Start date
2025-03-10
Completion date
2025-10-30
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breathing, Mouth, Kinesiophobia, Muscle Relaxation, Pain, Postoperative

Keywords

kinesiophobia, pain, breathing complications, breathing yoga, PMRTs

Brief summary

The study aims to compare the effectiveness of breathing yoga and progressive muscle relaxation techniques in relieving pain, respiratory complications and kinesiophobia in liver transplant recipients. H1-0: Breathing yoga has no effect in reducing pain in liver transplant recipients. H1-1: Breathing yoga has an effect in reducing pain in liver transplant recipients. H2-0: Breathing yoga has no effect in reducing respiratory complications in liver transplant recipients. H2-1: Breathing yoga has an effect in reducing respiratory complications in liver transplant recipients. H3-0: Breathing yoga has no effect in relieving kinesiophobia in liver transplant recipients. H3-1: Breathing yoga has an effect in relieving kinesiophobia in liver transplant recipients. H4-0: PMRTs has no effect in reducing pain in liver transplant recipients. H4-1: PMRTs have an effect on reducing pain in liver transplant recipients. H5-0: PMRTs have no effect on reducing respiratory complications in liver transplant recipients. H5-1: PMRTs have an effect on reducing respiratory complications in liver transplant recipients. H6-0: PMRTs have no effect on relieving kinesiophobia in liver transplant recipients. H6-1: PMRTs have an effect on relieving kinesiophobia in liver transplant recipients.

Detailed description

Experimental group (Breathing Yoga): Data collection tools (patient introduction form, numerical rating scale, respiratory complications form, Tampa kinesiophobia scale) will be applied before the yoga breathing exercises intervention. Patients will be shown how to practice breathing yoga, and then they will be asked to do it. The stages of breathing yoga are as follows: Yoga Breathing Exercises: 1. Sama Vritti or "Equal Breathing": 2. Abdominal Breathing Techniques: 3. Nadi Shodhana or "Alternating Breathing": 4. Kapalabhati or "Skull Shining Breath": 5. Progressive Muscle Relaxation: 6. Guided Visualization: Patients will be given breathing yoga brochures. After discharge, patients will be asked to do breathing yoga once every 8 hours (3 times a day) for 3 months. Patients will be contacted by phone. For the application of the exercises, complications related to the disease, etc. After three months, patients will be invited to the outpatient clinic and during these outpatient clinic visits, scales and forms will be applied to these patients once again to collect posttest data. Experimental Group (Progressive Muscle Relaxation Techniques-PMRTs): Data collection tools (patient identification form, numerical rating scale, respiratory complications form, Tampa Kinesiophobia scale) will be applied before the progressive muscle relaxation exercise intervention. Progressive muscle relaxation exercises will be demonstrated to patients in practice, and then they will be asked to do them. PMRTs stages are as follows: The patient is placed in a semi-sitting/lying position in bed. While the patient is breathing in and out, 11 different muscle group tightening/releasing exercises are performed. PMRTs are performed by the researchers for 15-20 minutes on the patients. After PMRTs, patients are rested in a quiet and calm patient room. PMRTs brochures will be given to the patients. After the patients are discharged, they will be asked to perform PMRTs once every 8 hours (3 times a day) for 3 months. Patients will be contacted by phone. For the implementation of the exercises, complications related to the disease, etc. After three months, the patients will be invited to the outpatient clinic and during these outpatient clinic visits, the scales and forms will be applied to these patients once again to collect posttest data. Control group: Data collection tools (patient identification form, numerical rating scale, respiratory complications form, Tampa kinesiophobia scale) will be applied to the patients in the control group as part of the pretest. Patients with questions will be allowed to direct their questions to the researchers. After these questions are answered, no intervention will be made to the control group and the patients in the control group will not be contacted at any time for the next three months. After three months, the patients in the control group will be invited to the outpatient clinic and during these outpatient clinic visits, the scales and forms will be applied to these patients once again to collect posttest data. After the data collection process is completed, breathing yoga and progressive muscle relaxation exercises will be demonstrated to the control group patients if they wish. It will be supported with brochures. Patients will be informed that they can contact the researchers by phone for information/support regarding the applications.

Interventions

OTHERbreathing yoga

Yoga Breathing Exercises: 1. Sama Vritti or "Equal Breathing": 2. Abdominal Breathing Techniques: 3. Nadi Shodhana or "Alternating Breathing": 4. Kapalabhati or "Skull Shining Breath": 5. Progressive Muscle Relaxation: 6. Guided Visualization:

OTHERPMRTs-Progressive Muscle Relaxation Techniques

While patients are breathing in and out, tightening and releasing exercises are applied to 11 different muscle groups. It is applied for 15-20 minutes.

Sponsors

Bitlis Eren University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

It will be conducted as a randomized controlled experimental study in a pretestpost- test control group experimental model.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Successful liver transplantation, * Considered to be discharged after liver transplantation, * Being 18 years old or older, * No communication or language barriers, * Agreeing to do PMRTs, * Agreeing to do breathing yoga

Exclusion criteria

* Having any auditory or mental problems, * Wanting to leave the study, * Having difficulty/unable to do PMRTs, * Having any joint-knee and orthopedic disorders, * Having difficulty/unable to do breathing yoga.

Design outcomes

Primary

MeasureTime frameDescription
pain levelDischarged patients will be asked to perform breathing yoga/PMRT every 8 hours (three times a day) for three months. Posttest data will be collected at the end of the three months.Numerical Rating Scale (NRS): This scale, which is intended to determine the severity of pain, aims to have the patient describe their pain with numbers. In the form, 0 points are evaluated as "no pain", 1-3 points as "mild pain", 4-6 points as "moderate pain", and 7 and above points as "severe pain".

Secondary

MeasureTime frameDescription
Kinesiophobia levelDischarged patients will be asked to perform breathing yoga/PMRT every 8 hours (three times a day) for three months. Posttest data will be collected at the end of the three months.Tampa Kinesiophobia Scale (TKS): TKS is a 17-question questionnaire that has been validated and reliable in Turkish and is used to determine the presence of kinesiophobia. A 4-point Likert scoring system is used for each question in the scale. As a result of the survey, the person receives a total score between 17-68 according to the answers they give. A high score on the scale indicates that the person has high kinesiophobia.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORŞerafettin OKUTAN, PhD.

Bitlis Eren University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026